Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Programming parameters of subthalamic deep brain stimulators in Parkinson's disease from a controlled trial.

Knudsen K, Krack P, Tonder L, Houeto JL, Rau J, Schade-Brittinger C, Hartmann A, Hälbig TD, Paschen S, Barbe MT, Kühn A, Fraix V, Brefel-Courbon C, Vesper J, Maltête D, Sixel-Döring F, Weiss D, Witjas T, Thobois S, Agid Y, Schnitzler A, Schuepbach WMM, Timmermann L, Damier P, Vidailhet M, Deuschl G; EARLYSTIM study group.

Parkinsonism Relat Disord. 2019 Aug;65:217-223. doi: 10.1016/j.parkreldis.2019.05.023. Epub 2019 Jun 18.

PMID:
31257096
2.

How do Parkinson's disease patients manage Ramadan fasting? An observational study.

Kamel WA, Al Hashel JY, Damier P.

Rev Neurol (Paris). 2019 Oct;175(9):560-563. doi: 10.1016/j.neurol.2018.12.008. Epub 2019 Jun 5.

PMID:
31176513
3.

Decreased level of consciousness due to a depleted deep brain stimulator battery: Paving the way to wake up the brain?

Kamel WA, Al-Hashel JY, Damier P, Abdulsalam AJ.

Rev Neurol (Paris). 2019 Apr;175(4):274-275. doi: 10.1016/j.neurol.2018.06.009. Epub 2019 Mar 14. No abstract available.

PMID:
30879605
4.

Quality of life predicts outcome of deep brain stimulation in early Parkinson disease.

Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, Hälbig TD, Pineau F, Falk A, Paschen L, Paschen S, Volkmann J, Dafsari HS, Barbe MT, Fink GR, Kühn A, Kupsch A, Schneider GH, Seigneuret E, Fraix V, Kistner A, Chaynes PP, Ory-Magne F, Brefel-Courbon C, Vesper J, Wojtecki L, Derrey S, Maltête D, Damier P, Derkinderen P, Sixel-Döring F, Trenkwalder C, Gharabaghi A, Wächter T, Weiss D, Pinsker MO, Regis JM, Witjas T, Thobois S, Mertens P, Knudsen K, Schade-Brittinger C, Houeto JL, Agid Y, Vidailhet M, Timmermann L, Deuschl G; EARLYSTIM study group.

Neurology. 2019 Mar 5;92(10):e1109-e1120. doi: 10.1212/WNL.0000000000007037. Epub 2019 Feb 8. Erratum in: Neurology. 2019 Jun 11;92(24):1166.

5.

PLA2G6-related parkinsonism presenting as adolescent behavior.

Kamel WA, Al-Hashel JY, Abdulsalam AJ, Damier P, Al-Mejalhem AY.

Acta Neurol Belg. 2018 Aug 17. doi: 10.1007/s13760-018-1003-z. [Epub ahead of print] No abstract available.

PMID:
30120687
6.

Deep brain stimulation does not enhance neuroinflammation in multiple system atrophy.

Lopez-Cuina M, Fernagut PO, Canron MH, Vital A, Lannes B, De Paula AM, Streichenberger N, Guehl D, Damier P, Eusebio A, Houeto JL, Tison F, Tranchant C, Viallet F, Witjas T, Thobois S, Meissner WG.

Neurobiol Dis. 2018 Oct;118:155-160. doi: 10.1016/j.nbd.2018.07.016. Epub 2018 Jul 17.

PMID:
30026036
7.

The Psychiatric Neuromodulation Unit: Implementation and Management.

Sauvaget A, Poulet E, Mantovani A, Bulteau S, Damier P, Moutaud B, Paternoster M, de Bartolomeis A, DʼUrso G.

J ECT. 2018 Dec;34(4):211-219. doi: 10.1097/YCT.0000000000000513. Review.

PMID:
29944606
8.

Treatment of refractory headache secondary to intracranial endovascular procedure by transcutaneous electrical nerve stimulation of the occipital nerve.

Nguyen JP, Raoul S, Desal H, Bourcier R, Kuhn E, Dixneuf V, Damier P, Lefaucheur JP, Nizard J.

Neurophysiol Clin. 2018 Oct;48(5):309-312. doi: 10.1016/j.neucli.2018.05.041. Epub 2018 Jun 15.

PMID:
29910144
9.

An unusual initial presentation of Parkinson's disease: unilateral standing leg tremor.

Al-Hashel JY, Kamel WA, Damier P, Abdulsalam AJ.

Acta Neurol Belg. 2018 May 5. doi: 10.1007/s13760-018-0920-1. [Epub ahead of print] No abstract available.

PMID:
29728905
10.

Heterogeneous pattern of autonomic dysfunction in Parkinson's disease.

Leclair-Visonneau L, Magy L, Volteau C, Clairembault T, Le Dily S, Préterre C, Peyre A, Damier P, Neunlist M, Péréon Y, Derkinderen P.

J Neurol. 2018 Apr;265(4):933-941. doi: 10.1007/s00415-018-8789-8. Epub 2018 Feb 20.

11.

High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.

Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga JM, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G.

Eur J Neurol. 2018 Jan;25(1):120-127. doi: 10.1111/ene.13474. Epub 2017 Oct 23.

PMID:
28960663
12.

L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Rascol O; of the COPARK Study Group.

Eur J Neurol. 2017 Dec;24(12):1532-1538. doi: 10.1111/ene.13466. Epub 2017 Oct 9.

PMID:
28940893
13.

Association Between Motor Symptoms and Brain Metabolism in Early Huntington Disease.

Gaura V, Lavisse S, Payoux P, Goldman S, Verny C, Krystkowiak P, Damier P, Supiot F, Bachoud-Levi AC, Remy P.

JAMA Neurol. 2017 Sep 1;74(9):1088-1096. doi: 10.1001/jamaneurol.2017.1200.

14.

Confusing Terminology-Neuroleptic Malignant Syndrome vs Malignant Hyperthermia-Reply.

Damier P, Al-Hashel J.

JAMA Neurol. 2017 Aug 1;74(8):1013. doi: 10.1001/jamaneurol.2017.0825. No abstract available.

PMID:
28558105
15.

Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease.

Nguyen JP, Suarez A, Kemoun G, Meignier M, Le Saout E, Damier P, Nizard J, Lefaucheur JP.

Neurophysiol Clin. 2017 Feb;47(1):47-53. doi: 10.1016/j.neucli.2017.01.001. Epub 2017 Feb 1.

PMID:
28161090
16.

Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.

Damier P, Al-Hashel J.

JAMA Neurol. 2017 Feb 1;74(2):233-237. doi: 10.1001/jamaneurol.2016.4291. Review.

PMID:
28027343
17.

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures.

Ben-Ari Y, Damier P, Lemonnier E.

Front Cell Neurosci. 2016 Apr 14;10:90. doi: 10.3389/fncel.2016.00090. eCollection 2016.

18.

Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsy.

Leclair-Visonneau L, Rouaud T, Debilly B, Durif F, Houeto JL, Kreisler A, Defebvre L, Lamy E, Volteau C, Nguyen JM, Dily SL, Damier P, Boutoleau-Bretonnière C, Lejeune P, Derkinderen P.

Clin Neurol Neurosurg. 2016 Jul;146:35-9. doi: 10.1016/j.clineuro.2016.04.021. Epub 2016 Apr 27.

PMID:
27136096
19.

Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesia.

Pouclet-Courtemanche H, Rouaud T, Thobois S, Nguyen JM, Brefel-Courbon C, Chereau I, Cuny E, Derost P, Eusebio A, Guehl D, Laurencin C, Mertens P, Ory-Magne F, Raoul S, Regis J, Ulla M, Witjas T, Burbaud P, Rascol O, Damier P.

Neurology. 2016 Feb 16;86(7):651-9. doi: 10.1212/WNL.0000000000002370. Epub 2016 Jan 20.

PMID:
26791148
20.

Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literature.

Meissner WG, Laurencin C, Tranchant C, Witjas T, Viallet F, Guehl D, Damier P, Houeto JL, Tison F, Eusebio A, Vital A, Streichenberger N, Lannes B, Maues de Paula A, Thobois S.

Parkinsonism Relat Disord. 2016 Mar;24:69-75. doi: 10.1016/j.parkreldis.2016.01.005. Epub 2016 Jan 7. Review.

PMID:
26778473
21.

Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.

Damier P, Hammond C, Ben-Ari Y.

Clin Neuropharmacol. 2016 Jan-Feb;39(1):57-9. doi: 10.1097/WNF.0000000000000114.

PMID:
26757306
22.

Subjective sleep dysfunction and insomnia symptoms in Parkinson's disease: Insights from a cross-sectional evaluation of the French CoPark cohort.

Ratti PL, Nègre-Pagès L, Pérez-Lloret S, Manni R, Damier P, Tison F, Destée A, Rascol O.

Parkinsonism Relat Disord. 2015 Nov;21(11):1323-9. doi: 10.1016/j.parkreldis.2015.09.025. Epub 2015 Sep 10.

PMID:
26411501
23.

Why do Parkinson's Disease Patients Sometimes Make Wrong Decisions?

Damier P.

J Parkinsons Dis. 2015;5(3):637-42. doi: 10.3233/JPD-150600. Review.

PMID:
26406144
24.

Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.

Cleret de Langavant L, Sudraud S, Verny C, Krystkowiak P, Simonin C, Damier P, Demonet JF, Supiot F, Rialland A, Schmitz D, Maison P, Youssov K, Bachoud-Lévi AC.

PLoS One. 2015 May 26;10(5):e0128209. doi: 10.1371/journal.pone.0128209. eCollection 2015.

25.

Falls in ambulatory non-demented patients with Parkinson's disease.

Rascol O, Perez-Lloret S, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Tison F, Negre-Pages L.

J Neural Transm (Vienna). 2015 Oct;122(10):1447-55. doi: 10.1007/s00702-015-1396-2. Epub 2015 Apr 7.

PMID:
25845678
26.

A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.

Carapito R, Paul N, Untrau M, Le Gentil M, Ott L, Alsaleh G, Jochem P, Radosavljevic M, Le Caignec C, David A, Damier P, Isidor B, Bahram S.

Mov Disord. 2015 Mar;30(3):423-7. doi: 10.1002/mds.26115. Epub 2014 Dec 27.

PMID:
25545163
27.

Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease.

Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Destée A, Meissner WG, Schelosky L, Tison F, Rascol O.

JAMA Neurol. 2014 Jul 1;71(7):884-90. doi: 10.1001/jamaneurol.2014.753.

PMID:
24839938
28.

Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort.

Désaméricq G, Dolbeau G, Verny C, Charles P, Durr A, Youssov K, Simonin C, Azulay JP, Tranchant C, Goizet C, Damier P, Broussolle E, Demonet JF, Morgado G, Cleret de Langavant L, Macquin-Mavier I, Bachoud-Lévi AC, Maison P.

PLoS One. 2014 Jan 15;9(1):e85430. doi: 10.1371/journal.pone.0085430. eCollection 2014.

29.

Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidailhet M, Rascol O; NS-Park CIC Network.

Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050. Epub 2013 Dec 26.

PMID:
24371304
30.

The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.

Klebe S, Golmard JL, Nalls MA, Saad M, Singleton AB, Bras JM, Hardy J, Simon-Sanchez J, Heutink P, Kuhlenbäumer G, Charfi R, Klein C, Hagenah J, Gasser T, Wurster I, Lesage S, Lorenz D, Deuschl G, Durif F, Pollak P, Damier P, Tison F, Durr A, Amouyel P, Lambert JC, Tzourio C, Maubaret C, Charbonnier-Beaupel F, Tahiri K, Vidailhet M, Martinez M, Brice A, Corvol JC; French Parkinson's Disease Genetics Study Group; International Parkinson's Disease Genomics Consortium (IPDGC).

J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):666-73. doi: 10.1136/jnnp-2012-304475. Epub 2013 Feb 13.

31.

Neurostimulation for Parkinson's disease with early motor complications.

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

32.

Continuous buccolingual masticatory dyskinesia in Parkinson's disease.

Meyniel C, Derkinderen P, Giumelli B, Damier P.

BMJ Case Rep. 2012 Sep 25;2012. pii: bcr0920080910. doi: 10.1136/bcr.09.2008.0910.

33.

Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.

Barbin L, Leux C, Sauleau P, Meyniel C, Nguyen JM, Pereon Y, Damier P.

Parkinsonism Relat Disord. 2013 Feb;19(2):165-70. doi: 10.1016/j.parkreldis.2012.08.012. Epub 2012 Sep 20.

PMID:
23000298
34.

Prospective evaluation of behavioral scales in the behavioral variant of frontotemporal dementia.

Boutoleau-Bretonnière C, Lebouvier T, Volteau C, Jaulin P, Lacomblez L, Damier P, Thomas-Anterion C, Vercelletto M.

Dement Geriatr Cogn Disord. 2012;34(2):75-82. Epub 2012 Aug 23.

PMID:
22922703
35.

EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?

Lesage S, Condroyer C, Klebe S, Lohmann E, Durif F, Damier P, Tison F, Anheim M, Honoré A, Viallet F, Bonnet AM, Ouvrard-Hernandez AM, Vidailhet M, Durr A, Brice A; French Parkinson's Disease Genetics Study Group.

Neurobiol Aging. 2012 Sep;33(9):2233.e1-2233.e5. doi: 10.1016/j.neurobiolaging.2012.05.006. Epub 2012 Jun 1.

36.

pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study.

Chaumeil MM, Valette J, Baligand C, Brouillet E, Hantraye P, Bloch G, Gaura V, Rialland A, Krystkowiak P, Verny C, Damier P, Remy P, Bachoud-Levi AC, Carlier P, Lebon V.

J Cereb Blood Flow Metab. 2012 May;32(5):771-9. doi: 10.1038/jcbfm.2012.15. Epub 2012 Feb 29.

37.

[Enteric nervous system and Parkinson's disease].

Paillusson S, Lebouvier T, Pouclet H, Coron E, Bruley des Varannes S, Damier P, Neunlist M, Derkinderen P.

Rev Med Interne. 2012 Jun;33(6):335-8. doi: 10.1016/j.revmed.2012.01.004. Epub 2012 Feb 6. Review. French.

PMID:
22318211
38.

Subthalamic nucleus stimulation reverses spinal motoneuron activity in parkinsonian patients.

Raoul S, Roualdes V, Deligny C, Leduc D, Lamy JC, Lackmy-Vallée A, N'guyen JP, Damier P, Katz R.

Brain. 2012 Jan;135(Pt 1):139-47. doi: 10.1093/brain/awr267. Epub 2011 Nov 10.

PMID:
22075070
39.

Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia.

Boutoleau-Bretonnière C, Lebouvier T, Delaroche O, Lamy E, Evrard C, Charriau T, Bretonnière C, Damier P, Derkinderen P, Vercelletto M.

J Alzheimers Dis. 2012;28(2):323-36. doi: 10.3233/JAD-2011-110761.

PMID:
22008265
40.

Surgery for tardive dyskinesia.

Thobois S, Poisson A, Damier P.

Int Rev Neurobiol. 2011;98:289-96. doi: 10.1016/B978-0-12-381328-2.00012-2. Review.

PMID:
21907092
41.

Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease.

Lelan F, Boyer C, Thinard R, Rémy S, Usal C, Tesson L, Anegon I, Neveu I, Damier P, Naveilhan P, Lescaudron L.

Parkinsons Dis. 2011;2011:987084. doi: 10.4061/2011/987084. Epub 2011 Jun 28.

42.

Singular DYT6 phenotypes in association with new THAP1 frameshift mutations.

Blanchard A, Roubertie A, Simonetta-Moreau M, Ea V, Coquart C, Frederic MY, Gallouedec G, Adenis JP, Benatru I, Borg M, Burbaud P, Calvas P, Cif L, Damier P, Destee A, Faivre L, Guyant-Marechal L, Janik P, Janoura S, Kreisler A, Lusakowska A, Odent S, Potulska-Chromik A, Rudzińska M, Thobois S, Vuillaume I, Tranchant C, Tuffery-Giraud S, Coubes P, Sablonnière B, Claustres M, Collod-Béroud G.

Mov Disord. 2011 Aug 1;26(9):1775-7. doi: 10.1002/mds.23641. Epub 2011 Apr 25. No abstract available.

PMID:
21520283
43.

Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson's disease: preliminary analysis from the French COPARK cohort.

Perez-Lloret S, Nègre-Pagès L, Ojero-Senard A, Damier P, Destée A, Tison F, Merello M, Rascol O; COPARK Study Group.

Eur J Neurol. 2012 Jan;19(1):28-37. doi: 10.1111/j.1468-1331.2011.03402.x. Epub 2011 Apr 1.

PMID:
21453441
44.

Colonic neuropathology is independent of olfactory dysfunction in Parkinson's disease.

Lebouvier T, Pouclet H, Coron E, Drouard A, N'Guyen JM, Roy M, Vavasseur F, Bruley des Varannes S, Damier P, Neunlist M, Derkinderen P, Rouaud T.

J Parkinsons Dis. 2011;1(4):389-94. doi: 10.3233/JPD-2011-11061.

PMID:
23939345
45.

Screening of the THAP1 gene in patients with early-onset dystonia: myoclonic jerks are part of the dystonia 6 phenotype.

Clot F, Grabli D, Burbaud P, Aya M, Derkinderen P, Defebvre L, Damier P, Krystkowiak P, Pollak P, Leguern E, San C, Camuzat A, Roze E, Vidailhet M, Durr A, Brice A.

Neurogenetics. 2011 Feb;12(1):87-9. doi: 10.1007/s10048-010-0264-3. Epub 2010 Nov 26. No abstract available.

PMID:
21110056
46.

Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population.

Saad M, Lesage S, Saint-Pierre A, Corvol JC, Zelenika D, Lambert JC, Vidailhet M, Mellick GD, Lohmann E, Durif F, Pollak P, Damier P, Tison F, Silburn PA, Tzourio C, Forlani S, Loriot MA, Giroud M, Helmer C, Portet F, Amouyel P, Lathrop M, Elbaz A, Durr A, Martinez M, Brice A; French Parkinson's Disease Genetics Study Group.

Hum Mol Genet. 2011 Feb 1;20(3):615-27. doi: 10.1093/hmg/ddq497. Epub 2010 Nov 17.

PMID:
21084426
47.

Repetitive behaviours in patients with Gilles de la Tourette syndrome: tics, compulsions, or both?

Worbe Y, Mallet L, Golmard JL, Béhar C, Durif F, Jalenques I, Damier P, Derkinderen P, Pollak P, Anheim M, Broussolle E, Xie J, Mesnage V, Mondon K, Viallet F, Jedynak P, Ben Djebara M, Schüpbach M, Pelissolo A, Vidailhet M, Agid Y, Houeto JL, Hartmann A.

PLoS One. 2010 Sep 24;5(9):e12959. doi: 10.1371/journal.pone.0012959.

48.

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.

Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N'Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P.

PLoS One. 2010 Sep 14;5(9):e12728. doi: 10.1371/journal.pone.0012728.

49.

Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.

Rascol O, Azulay JP, Blin O, Bonnet AM, Brefel-Courbon C, Césaro P, Damier P, Debilly B, Durif F, Galitzky M, Grouin JM, Pennaforte S, Villafane G, Yaici S, Agid Y.

Mov Disord. 2010 Feb 15;25(3):368-76. doi: 10.1002/mds.22922.

PMID:
20063435
50.

Follow-up study of the GIGYF2 gene in French families with Parkinson's disease.

Lesage S, Condroyer C, Lohman E, Troiano A, Tison F, Viallet F, Damier P, Tranchant C, Vidhaillet M, Ouvrard-Hernandez AM, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group (FPDGSG).

Neurobiol Aging. 2010 Jun;31(6):1069-71; discussion 1072-4. doi: 10.1016/j.neurobiolaging.2009.06.008. Epub 2009 Dec 8.

PMID:
20004041

Supplemental Content

Loading ...
Support Center